119 related articles for article (PubMed ID: 21157201)
1. Prognostic value of bone scintigraphy in cancer patients with osteonecrosis of the jaw.
Van den Wyngaert T; Huizing MT; Fossion E; Vermorken JB
Clin Nucl Med; 2011 Jan; 36(1):17-20. PubMed ID: 21157201
[TBL] [Abstract][Full Text] [Related]
2. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of bone scintigraphy in cancer patients with osteonecrosis of the jaw: is there something missing?
Hakim SG
Clin Nucl Med; 2012 Sep; 37(9):874. PubMed ID: 22885823
[No Abstract] [Full Text] [Related]
4. Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?
Lesclous P; Abi Najm S; Carrel JP; Baroukh B; Lombardi T; Willi JP; Rizzoli R; Saffar JL; Samson J
Bone; 2009 Nov; 45(5):843-52. PubMed ID: 19631301
[TBL] [Abstract][Full Text] [Related]
5. Myocardial perfusion scintigraphy after cardiac arrest: on the pathophysiology of cardiac death.
Javadi H; Assadi M
Clin Nucl Med; 2012 Sep; 37(9):874-5. PubMed ID: 22885825
[No Abstract] [Full Text] [Related]
6. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.
Raje N; Woo SB; Hande K; Yap JT; Richardson PG; Vallet S; Treister N; Hideshima T; Sheehy N; Chhetri S; Connell B; Xie W; Tai YT; Szot-Barnes A; Tian M; Schlossman RL; Weller E; Munshi NC; Van Den Abbeele AD; Anderson KC
Clin Cancer Res; 2008 Apr; 14(8):2387-95. PubMed ID: 18413829
[TBL] [Abstract][Full Text] [Related]
7. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw.
Dore F; Filippi L; Biasotto M; Chiandussi S; Cavalli F; Di Lenarda R
J Nucl Med; 2009 Jan; 50(1):30-5. PubMed ID: 19091894
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
Okui T; Kobayashi Y; Tsujimoto M; Satoh K; Toyama H; Matsuo K
Ann Nucl Med; 2020 Sep; 34(9):620-628. PubMed ID: 32557015
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
[TBL] [Abstract][Full Text] [Related]
10. Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early.
Yamamoto Y; Mitsunaga S; Horikawa A; Hino A; Kurihara H
Ann Nucl Med; 2020 Jan; 34(1):74-79. PubMed ID: 31705367
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
[TBL] [Abstract][Full Text] [Related]
12. Positive predictive value of the International Classification of Diseases, 10th revision, codes to identify osteonecrosis of the jaw in patients with cancer.
Gammelager H; Erichsen R; Antonsen S; Nørholt SE; Neumann-Jensen B; Ehrenstein V; Acquavella J; Sørensen HT
Cancer Epidemiol; 2012 Aug; 36(4):381-3. PubMed ID: 22534488
[TBL] [Abstract][Full Text] [Related]
13. Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.
Watanabe S; Nakajima K; Mizokami A; Yaegashi H; Noguchi N; Kawashiri S; Inokuchi M; Kinuya S
Ann Nucl Med; 2017 Apr; 31(3):201-210. PubMed ID: 27995542
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of SPECT/CT in the assessment of inflammatory jaw pathologies.
Modabber A; Schick D; Möhlhenrich SC; Mottaghy FM; Verburg FA; Hölzle F; Gerressen M
Eur J Radiol; 2020 Apr; 125():108917. PubMed ID: 32120276
[TBL] [Abstract][Full Text] [Related]
15. Bone and gallium scans in postradiotherapy osteonecrosis of the jaw.
Epstein JB; Wong FL; Dickens A; Szasz I; Lepawsky M
Head Neck; 1992; 14(4):288-92. PubMed ID: 1517078
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis of the jaw: an update and review of recommendations.
Novince CM; Ward BB; McCauley LK
Cells Tissues Organs; 2009; 189(1-4):275-83. PubMed ID: 18765930
[TBL] [Abstract][Full Text] [Related]
17. Natural history of osteonecrosis of the jaw in patients with multiple myeloma.
Badros A; Terpos E; Katodritou E; Goloubeva O; Kastritis E; Verrou E; Zervas K; Baer MR; Meiller T; Dimopoulos MA
J Clin Oncol; 2008 Dec; 26(36):5904-9. PubMed ID: 19018084
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of bisphosphonate-associated osteonecrosis: Prognostic score and long-term results.
Reich W; Bilkenroth U; Schubert J; Wickenhauser C; Eckert AW
J Craniomaxillofac Surg; 2015 Nov; 43(9):1809-22. PubMed ID: 26321065
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
Vahtsevanos K; Kyrgidis A; Verrou E; Katodritou E; Triaridis S; Andreadis CG; Boukovinas I; Koloutsos GE; Teleioudis Z; Kitikidou K; Paraskevopoulos P; Zervas K; Antoniades K
J Clin Oncol; 2009 Nov; 27(32):5356-62. PubMed ID: 19805682
[TBL] [Abstract][Full Text] [Related]
20. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
